2022
DOI: 10.1016/j.idcr.2022.e01463
|View full text |Cite
|
Sign up to set email alerts
|

Laryngeal blastomycosis with subsequent heart failure from itraconazole therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Therefore, there is an urgent need to improve the drug release and absorption with an aim to lower the drug's side effect for causing heart failure. [29][30][31] To solve this problem, the M-Silica xerogel was used as an ITZ carrier and the loaded waterinsoluble drug was found to be amorphous in the M-Silica xerogel, and the entrapped micelles exerted certain functions to avoid drug re-crystallization in the system. Furthermore, the characteristics of the M-Silica xerogel as well as its drug-release management principles were systemically investigated, which could give a strong foundation for the further study of silica xerogel drug-delivery systems.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, there is an urgent need to improve the drug release and absorption with an aim to lower the drug's side effect for causing heart failure. [29][30][31] To solve this problem, the M-Silica xerogel was used as an ITZ carrier and the loaded waterinsoluble drug was found to be amorphous in the M-Silica xerogel, and the entrapped micelles exerted certain functions to avoid drug re-crystallization in the system. Furthermore, the characteristics of the M-Silica xerogel as well as its drug-release management principles were systemically investigated, which could give a strong foundation for the further study of silica xerogel drug-delivery systems.…”
Section: Introductionmentioning
confidence: 99%